Back to Journals » International Journal of Nanomedicine » Volume 12

Inorganic nanoparticles kill Toxoplasma gondii via changes in redox status and mitochondrial membrane potential

Authors Adeyemi OS, Murata Y, Sugi T, Kato K

Received 12 September 2016

Accepted for publication 22 November 2016

Published 28 February 2017 Volume 2017:12 Pages 1647—1661

DOI https://doi.org/10.2147/IJN.S122178

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Alexander Kharlamov

Peer reviewer comments 3

Editor who approved publication: Dr Thomas J Webster

Oluyomi Stephen Adeyemi,1,2 Yuho Murata,1 Tatsuki Sugi,1 Kentaro Kato1

1National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan; 2Medicinal Biochemistry and Toxicology Laboratory, Department of Biological Sciences, Landmark University, Omu-Aran, Nigeria

Abstract: This study evaluated the anti-Toxoplasma gondii potential of gold, silver, and platinum nanoparticles (NPs). Inorganic NPs (0.01–1,000 µg/mL) were screened for antiparasitic activity. The NPs caused >90% inhibition of T. gondii growth with EC50 values of ≤7, ≤1, and ≤100 µg/mL for gold, silver, and platinum NPs, respectively. The NPs showed no host cell cytotoxicity at the effective anti-T. gondii concentrations; the estimated selectivity index revealed a ≥20-fold activity toward the parasite versus the host cell. The anti-T. gondii activity of the NPs, which may be linked to redox signaling, affected the parasite mitochondrial membrane potential and parasite invasion, replication, recovery, and infectivity potential. Our results demonstrated the antiparasitic potential of NPs. The findings support the further exploration of NPs as a possible source of alternative and effective anti-T. gondii agents.

Keywords: antiparasite, drug screening, nanomedicine, toxoplasmosis

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]